83 related articles for article (PubMed ID: 8438246)
1. Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury.
Gregory CR; Huie P; Shorthouse R; Wang J; Rowan R; Billingham ME; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):120-1. PubMed ID: 8438246
[No Abstract] [Full Text] [Related]
2. Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells.
Morris RE; Cao W; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse RA
Transplant Proc; 1995 Feb; 27(1):430-1. PubMed ID: 7879049
[No Abstract] [Full Text] [Related]
3. Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
Belitsky P; Gulanikar A; He G; Gupta R
Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272
[No Abstract] [Full Text] [Related]
4. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
Gregory CR; Pratt RE; Huie P; Shorthouse R; Dzau VJ; Billingham ME; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):770-1. PubMed ID: 7679842
[No Abstract] [Full Text] [Related]
5. Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.
Mohacsi PJ; Joshi A; Wang J; Morris RE; Billingham ME
Transplant Proc; 1994 Dec; 26(6):3255-9. PubMed ID: 7998133
[No Abstract] [Full Text] [Related]
6. Cyclosporine inhibits intimal hyperplasia in rat aortic allografts.
Stoltenberg R; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
Transplant Proc; 1994 Oct; 26(5):2569-70. PubMed ID: 7940794
[No Abstract] [Full Text] [Related]
7. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
Schmidbauer G; Hancock WW; Wasowska BA; Sablinski T; Kupiec-Weglinski JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
[No Abstract] [Full Text] [Related]
8. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
[TBL] [Abstract][Full Text] [Related]
9. LEW-to-F344 carotid artery allografts: analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses.
Hancock WW; Shi C; Picard MH; Bianchi C; Russell ME
Transplantation; 1995 Dec; 60(12):1565-72. PubMed ID: 8545891
[TBL] [Abstract][Full Text] [Related]
10. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
[No Abstract] [Full Text] [Related]
11. The immunosuppressive effect of rapamycin on pancreaticoduodenal transplants in the rat.
Chen HF; Wu JP; Luo HY; Daloze PM
Transplant Proc; 1991 Aug; 23(4):2239-40. PubMed ID: 1714651
[No Abstract] [Full Text] [Related]
12. Differential effects of modern immunosuppressive agents on the development of intimal hyperplasia.
Waller JR; Brook NR; Bicknell GR; Nicholson ML
Transpl Int; 2004 Jan; 17(1):9-14. PubMed ID: 14551676
[TBL] [Abstract][Full Text] [Related]
13. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
14. Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia.
Waller JR; Murphy GJ; Bicknell GR; Toomey D; Nicholson ML
Br J Surg; 2002 Nov; 89(11):1390-5. PubMed ID: 12390379
[TBL] [Abstract][Full Text] [Related]
15. Enhanced nitric oxide production induced by the administration of L-arginine does not inhibit arterial neointimal formation after overwhelming alloimmune injury.
Gregory CR; Cooke JP; Patz JD; Berryman ER; Shorthouse R; Morris RE
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):58-66. PubMed ID: 8820084
[TBL] [Abstract][Full Text] [Related]
16. Influence of rat strain on rapamycin's kidney effects.
DiJoseph JF; Mihatsch MJ; Sehgal SN
Transplant Proc; 1993 Feb; 25(1 Pt 1):714-5. PubMed ID: 8438451
[No Abstract] [Full Text] [Related]
17. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
Moien-Afshari F; Choy JC; McManus BM; Laher I
J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin effects on immunologic reconstitution.
Vogelsang GB; Hess AD
Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
[No Abstract] [Full Text] [Related]
19. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
Stepkowski SM; Kahan BD
Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
[No Abstract] [Full Text] [Related]
20. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
